uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
cDNA cloning, expression studies and chromosome mapping of human type I serine/threonine kinase receptor ALK7 (ACVR1C)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Ludwig Institute for Cancer Research.
Show others and affiliations
2001 (English)In: Cytogenetics and Cell Genetics, ISSN 0301-0171, E-ISSN 1421-9816, Vol. 95, no 3-4, 157-162 p.Article in journal (Refereed) Published
Abstract [en]

Transforming growth factor-beta (TGF-beta) superfamily related growth factors signal by binding to transmembrane type I and type II receptor serine/threonine kinases (RSTK), which phosphorylate intracellular Smad transcription factors in response to ligand binding. Here we describe the cloning of the human type I RSTK activin receptor-like kinase 7 (ALK7), an orthologue of the previously identified rat ALK7. Nodal, a TGF-beta member expressed during embryonic development and implicated in developmental events like mesoderm formation and left-right axis specification, was recently shown to signal through ALK7. We found ALK7 mRNA to be most abundantly expressed in human brain, pancreas and colon. A cDNA encoding the open reading frame of ALK7 was obtained from a human brain cDNA library. Furthermore, a P1 artificial chromosome (PAC) clone containing the human ALK7 gene was isolated and fluorescent in situ hybridization (FISH) on metaphase chromosomes identified the gene locus as chromosome 2q24.1-->q3. To test the functionality of the ALK7 signaling, we generated recombinant adenoviruses containing a constitutively active form of ALK7 (Ad-caALK7), which is capable of activating downstream targets in a ligand independent manner. Infection with Ad-caALK7 of MIN6 insulinoma cells, in which ALK7 has previously been shown to be endogenously expressed, led to a marked increase in the phosphorylation of Smad2, a signaling molecule also used by TGF-betas and activins.

Place, publisher, year, edition, pages
2001. Vol. 95, no 3-4, 157-162 p.
Keyword [en]
Activin Receptors; Type I/*genetics/metabolism, Amino Acid Sequence, Brain Chemistry/*genetics, Chromosome Mapping, Cloning; Molecular, DNA-Binding Proteins/metabolism, Gene Expression, Gene Library, Humans, Insulinoma/genetics, Molecular Sequence Data, Phosphorylation, Protein-Serine-Threonine Kinases/*genetics/metabolism, Research Support; Non-U.S. Gov't, Signal Transduction/genetics, Trans-Activators/metabolism, Tumor Cells; Cultured
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-73642DOI: 10.1159/000059339PubMedID: 12063393OAI: oai:DiVA.org:uu-73642DiVA: diva2:101552
Available from: 2005-06-13 Created: 2005-06-13 Last updated: 2013-10-30Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=12063393&dopt=Citation

Search in DiVA

By author/editor
Morén, AnitaMoustakas, Aristidisten Dijke, Peter
By organisation
Ludwig Institute for Cancer Research
In the same journal
Cytogenetics and Cell Genetics
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 285 hits
ReferencesLink to record
Permanent link

Direct link